The shares of ViewRay, Inc. (NASDAQ:VRAY) has been pegged with a rating of Overweight by Piper Jaffray in its latest research note that was published on June 18th, 2019. The research company has also assigned a $15 price target. Piper Jaffray wasn’t the only research firm that published a report of ViewRay, Inc., with other equities research analysts also giving their opinion on the stock. B. Riley FBR advised investors in its research note published on March 15th, 2019, to Buy the VRAY stock while also putting a $12 price target. The stock had earned Equal-Weight rating from Morgan Stanley when it published its report on December 11th, 2018. That day the Morgan Stanley set price target on the stock to $7. The stock was given Outperform rating by Robert W. Baird in its report released on October 19th, 2018. Jefferies was of a view that VRAY is Buy in its latest report on July 3rd, 2018. B. Riley FBR, Inc. thinks that VRAY is worth Buy rating. This was contained in the firm’s report on February 8th, 2018 in which the stock’s price target was also moved to $13.50.
The consensus currently stands at a Hold while its average price target is $6.80. The price of the stock the last time has raised by 54.35% from its Week high price while it is raised higher than its 52-Week low price. A look at the stock’s other technical shows that its 14-day RSI now stands at 28.86.
The shares of the company added by 2.16% during the trading session on Thursday, reaching a low of $4.02 while ending the day at $4.26. During the trading session, a total of 1.68 million shares were traded which represents a 3.73% incline from the average session volume which is 1.74M shares. VRAY had ended its last session trading at 4.17. ViewRay, Inc. currently has a market cap of $371.30M while its P/E earnings growth sits at 4.18, with a beta of 1.38. ViewRay, Inc. debt-to-equity ratio currently stands at 0.45, while its quick ratio hovers at 2.90. VRAY 52-week low price stands at $2.76 while its 52-week high price is $10.73.
ViewRay, Inc. has the potential to record -1.22 EPS for the current fiscal year, according to equities analysts.
Investment analysts at Citigroup published a research note on May 10th, 2019 where it informed investors and clients that Anthem, Inc. (NYSE:ANTM) is now rated as Buy. Their price target on the stock stands at $325. B. Riley FBR also rated ANTM as Reiterated on March 15th, 2019, with its price target of $12 suggesting that ANTM could surge by 23.99% from its current share price. Even though the stock has been trading at $267.88/share, analysts expect it to surge higher by -2.55% to reach $343.45/share. It started the day trading at $269.03 and traded between $260.82 and $261.06 throughout the trading session.
A look at its technical shows that ANTM’s 50-day SMA is 288.55 while its 200-day SMA stands at 281.68. The stock has a high of $317.99 for the year while the low is $227.16. The company’s P/E ratio currently sits at 16.95, while the P/B ratio is 2.18. At the moment, only of Anthem, Inc. shares were sold short. The company’s average trading volume currently stands at 1.40M shares, which means that the short-interest ratio is just 3.50 days. Over the past seven days, the company moved, with its shift of -4.76%. Looking further, the stock has dropped -6.00% over the past 90 days while it lost -17.59% over the last six months.
The change in the stock’s fortunes has led to several institutional investors altering their holdings of the stock. The Vanguard Group Inc bought more ANTM shares, increasing its portfolio by +0.74% during the last quarter. This move now sees The Vanguard Group Inc purchasing 141,073 shares in the last quarter, thus it now holds 19,100,771 shares of ANTM, with a total valuation of $5,627,278,144. T Rowe Price Associates Inc meanwhile sold more ANTM shares in the recently filed quarter, changing its stake to $4,995,465,493 worth of shares. BlackRock Fund Advisors followed the path by decreasing its ANTM portfolio by -0.45% in the quarter. This means that BlackRock Fund Advisors sold -55,363 shares in the last quarter and now controls 12,138,660 shares of the ANTM stock, with the valuation hitting $3,576,170,623.
Similarly, Fidelity Management Research Co decreased its Anthem, Inc. shares by -9.79% during the recently filed quarter. After selling -969,956 shares in the last quarter, the firm now controls 8,938,981 shares of Anthem, Inc. which are valued at $2,633,513,192. In the same vein, Wellington Management Co LLP decreased its Anthem, Inc. shares by during the most recent reported quarter. The firm sold -124,731 shares during the quarter which decreased its stakes to 8,045,620 shares and is now valued at $2,370,320,108. Following these latest developments, around 0.10% of Anthem, Inc. stocks are owned by institutional investors and hedge funds.